--:--:--LOCAL ·--:--UTC
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    US EQUITIESLAST CLOSE
    AAPL$333.69+1.02%
    MSFT$517.53+0.92%
    GOOGL$343.50+1.56%
    AMZN$251.52+1.33%
    NVDA$233.95+1.34%
    META$728.08+0.30%
    TSLA$370.59+4.65%
    NFLX$67.06-1.16%
    BRK.B$502.65+0.43%
    AVGO$355.14+3.35%
    DIS$102.19+0.85%
    SBUX$94.71-0.18%
    MCD$231.89+0.03%
    NKE$33.87-3.64%
    COST$920.65+0.62%
    WMT$104.26+0.00%
    HD$282.85+0.14%
    KO$85.65-0.52%
    PG$144.91+0.67%
    ORCL$142.30+3.06%
    CRM$234.69-0.84%
    ADBE$237.69-1.49%
    AMD$633.91+2.95%
    INTC$119.33-0.56%
    QCOM$184.87+1.53%
    CSCO$112.20+3.16%
    IBM$222.64-1.32%
    UBER$68.11+0.34%
    ABNB$162.43+1.22%
    SHOP$151.39+1.54%
    PYPL$52.80-0.49%
    COIN$183.00-3.32%
    PLTR$188.75-0.68%
    HOOD$112.74+1.43%
    JPM$332.38-0.24%
    V$360.66+0.23%
    MA$552.26+0.41%
    BAC$53.75+0.04%
    GS$902.56+0.66%
    LLY$1142.85-0.61%
    UNH$371.90+1.83%
    JNJ$256.03-1.02%
    PFE$27.80-1.14%
    XOM$164.01+0.12%
    BA$193.56+0.67%
    BABA$105.85-1.49%
    TSM$472.78+2.96%
    Plug stock market data into your AI agent — one command: Get your free API key →
    LoginGet API Key
    Company data coverage · NYSE

    ABT — Abbott Laboratories

    Data coverage, completeness and provenance for Abbott Laboratories in the Stock Market API — Health Care · Medical Devices.

    NYSE USA S&P 500
    Core-field completeness
    100.0%
    Statement periods
    FY2021–FY2025
    Filings archived
    0
    Price captured
    2026-10-04 22:48 UTC

    Profile

    Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

    Employees: 122,000 · Website: https://www.abbott.com · Profile fields populated: 75%

    Data completeness by statement

    Share of stored fields populated in the anchor reporting period (FY2025), primary source sec_edgar. Full per-field breakdown: GET /api/v1/companies/ABT/financials.

    Income statement10/10 fields (100.0%)
    Balance sheet12/14 fields (85.7%)
    Cash flow6/6 fields (100.0%)
    Per-share3/4 fields (75.0%)

    Financial statement coverage (USD)

    Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.

    PeriodPeriod end RevenueNet incomeTotal assetsTotal equity Fields populatedSource
    FY2025 2025-12-31 31 sec_edgar
    FY2024 2024-12-31 31 sec_edgar
    FY2023 2023-12-31 31 sec_edgar
    FY2022 2022-12-31 31 sec_edgar
    FY2021 2021-12-31 32 sec_edgar

    Get ABT data via the API

    Every number on this page is one API call away. Free API keys — no card required.

    Company profile

    Name, sector, industry, HQ, employees, market cap, source-tagged.

    GET /api/v1/companies/ABT

    Financial statements

    Multi-year statements with per-field source tags and completeness.

    GET /api/v1/companies/ABT/financials

    Computed ratios

    P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.

    GET /api/v1/companies/ABT/metrics/summary

    Filings archive

    Report PDFs with LLM-ready markdown conversions where available.

    GET /api/v1/companies/ABT/filings

    News & announcements

    Dated press releases and announcements with source links.

    GET /api/v1/companies/ABT/news

    Quick start

    Create a free key, then:

    curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/ABT

    Query ABT programmatically

    Free tier — instant API key. Built for AI agents.

    Other NYSE · Health Care companies covered

    Frequently Asked Questions

    What data does the API provide for ABT?
    Company profile, financial statements, computed ratios, price data, filings and news for ABT, via REST endpoints under /api/v1/companies/ABT. Every financial field carries a source tag for provenance.
    How complete is ABT's financial data?
    The anchor reporting period (FY2025) has 100.0% of the 17 core statement fields populated. Primary source: sec_edgar.
    What reporting periods are covered for ABT?
    5 fiscal-year periods are stored (FY2021–FY2025), with per-period field counts and source tags available via /api/v1/companies/ABT/financials.
    Where does ABT's data come from?
    Primary source for the latest statements: sec_edgar. The API records a source tag on every field and exposes them via /api/v1/companies/ABT/financials, so each value is traceable.